Bioventus Inc.BVSNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P8
Near historical low
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-3.99%
20247.64%
2023-8.51%
202230.63%
202131.68%
2020-2.72%
20193.55%
201816.28%
20172.82%
20168.00%